Cibus (CBUS) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 27, 2026)


CBUS Cibus Inc CBUS
53 GF Score
Price $1.36
GF Value $2.04
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Cibus Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Cibus's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


CBUS vs OTLK, INO, RANI: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Cibus's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cibus Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cibus's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Cibus's Margin of Safety % (DCF Earnings Based) falls into.


CBUS
53GF Score
Cibus Inc CBUS
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cibus (CBUS) Overvalued in 2026?

Based on GuruFocus' analysis, Cibus stock appears to be undervalued. The current stock price of $1.36 is trading 33.3% below its estimated GF Value™ of $2.04. GuruFocus considers Cibus to be Possible Value Trap.

Key valuation signals for CBUS:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $2.04 vs. price of $1.36 (33.3% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the CBUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cibus Business Description

Address 6455 Nancy Ridge Drive, San Diego, CA, USA, 92121
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
53GF Score

Get the complete analysis for CBUS

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.36
Price
$2.04
GF Value